It is unclear whether diabetes itself (with the lack of an association when hypoglycaemic drugs were not being used reflecting less severe diabetes) or particular hypoglycaemic medications (e.g. some may affect OATP transportation, in which case the association reflects a drug-interaction) affect risk of myopathy.24 This evidence concerns the gene SLCO1A2 and diabetes mellitus.